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Abstract
Purpose Exacerbated hydrogen cation  (H+) production is suggested to be a key determinant of fatigue in acute hypoxic 
conditions. This study, therefore, investigated the effects of  NaHCO3 ingestion on repeated 4 km TT cycling performance 
and post-exercise acid–base balance recovery in acute moderate hypoxic conditions.
Methods Ten male trained cyclists completed four repeats of 2 × 4 km cycling time trials  (TT1 and  TT2) with 40 min passive 
recovery, each on different days. Each TT series was preceded by supplementation of one of the 0.2 g kg−1 BM  NaHCO3 
(SBC2), 0.3 g kg−1 BM  NaHCO3 (SBC3), or a taste-matched placebo (0.07 g kg−1 BM sodium chloride; PLA), adminis-
tered in a randomized order. Supplements were administered at a pre-determined individual time to peak capillary blood 
bicarbonate concentration  ([HCO3−]). Each TT series was also completed in a normobaric hypoxic chamber set at 14.5% 
 FiO2 (~ 3000 m).
Results Performance was improved following SBC3 in both  TT1 (400.2 ± 24.1 vs. 405.9 ± 26.0 s; p = 0.03) and  TT2 
(407.2 ± 29.2 vs. 413.2 ± 30.8 s; p = 0.01) compared to PLA, displaying a very likely benefit in each bout. Compared to SBC2, 
a likely and possible benefit was also observed following SBC3 in  TT1 (402.3 ± 26.5 s; p = 0.15) and  TT2 (410.3 ± 30.8 s; 
p = 0.44), respectively. One participant displayed an ergolytic effect following SBC3, likely because of severe gastrointestinal 
discomfort, as SBC2 still provided ergogenic effects.
Conclusion NaHCO3 ingestion improves repeated exercise performance in acute hypoxic conditions, although the optimal 
dose is likely to be 0.3 g kg−1 BM.
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Introduction
Repeated bouts of high-intensity exercise are a fre-
quent feature of training and competition in athletes 
(Monedero and Donne 2000; Barnett 2006). The recov-
ery between these exercise bouts is an essential compo-
nent for determining the effectiveness of the subsequent 
bout. Enhanced recovery can allow athletes to tolerate 
greater training loads in the subsequent bout, potentially 
enhancing the post-training adaptation as a result (Bar-
nett 2006). Whereas, in competition, enhancing recovery 
is an important component to sustain performance within 
the subsequent bout. This is applicable to sports such as 
track cycling, swimming, or a rowing regatta series which 
involve heats, semi-finals, and finals within a short amount 
of time (Al-Nawaiseh et al. 2016; Monedero and Donne 
2000). Specifically, the gap between the men’s team pur-
suit first round and the final at the Rio 2016 Olympics was 
separated by just 60 min. Considering that most national 
and Olympic records are achieved within the preliminary 
rounds of these events (Al-Nawaiseh et al. 2016), this 
suggests that full recovery is not always possible during 
these time frames or that current recovery practices are not 
optimal. Therefore, interventions to improve recovery and 
sustain subsequent exercise performance are important.
A major factor that may hamper post-training recov-
ery and the subsequent bout of exercise is the metabolic 
disturbance that occurs following an initial high-intensity 
exercise bout (Barnett 2006). Ward et al. (2016) reported 
that the decline in pH and  HCO3− following a 4 km cycling 
time trial (TT; team pursuit distance) was substantial, 
and reflective of metabolic acidosis (pH 7.16 ± 0.08, 
 HCO3− 11.9 ± 2.3 mmol l−1), which was measured using 
capillary blood samples. Full recovery of such distur-
bances is likely to take over 75 min, as Callahan et al. 
(2017) reported  HCO3− was 6.2 mmol l−l below baseline 
at this point (19.5 ± 1.4 vs. 25.7 ± 1.0 mmol l−1). If only 
60 min is available for recovery, therefore, such as that 
during track cycling events, an existing acid–base bal-
ance perturbation will be evident. Although contentious 
(Westerblad 2016), critical rises in hydrogen cation  (H+) 
accumulation are linked to a reduction in both the release 
and uptake of calcium ions  (Ca2+) from the sarcoplasmic 
reticulum (Allen et al. 2008), disruption of key enzymes 
of the glycolytic pathway (Hollidge-Horvat et al. 1999), 
and a reduction in muscle excitability and action potentials 
by reducing the strong ion difference (SID) (Cairns and 
Lindinger 2008). In turn, this may hamper subsequent per-
formance by reducing the capability for muscle force pro-
duction (Cairns 2006; Fitts 2016). It is intuitive to suggest, 
therefore, that interventions to accelerate post-exercise 
recovery of acid–base balance could be beneficial for a 
subsequent bout of exercise.
The ingestion of sodium bicarbonate  (NaHCO3) has been 
shown to accelerate post-exercise acid–base balance recov-
ery and subsequent exercise performance (Pruscino et al. 
2008; Zabala et al. 2008, 2011; Gough et al. 2017a). Prus-
cino et al. (2008) reported a ‘trivial’ to ‘moderate’ benefit in 
the second bout of a 2 × 200 m freestyle swim (interspersed 
with a 30 min recovery) following pre-exercise ingestion of 
 NaHCO3. It was then later reported that  NaHCO3 ingestion 
30 min into a 90 min post-exercise recovery significantly 
improved subsequent cycling capacity at 100% peak mean 
minute power by 16.6% (Gough et al. 2017a). Both studies 
reported that capillary blood pH and  HCO3− recovery were 
accelerated and above baseline at the end of the recovery 
period, whereas the placebo condition failed to fully recover. 
This time frame between bouts might explain why ergogenic 
effects were observed, as this allowed pH and  HCO3− to 
recover sufficiently. Conversely, no effect of  NaHCO3 inges-
tion has been reported on three repeated Wingate tests 
separated shorter recovery time frames of between 15 and 
30 min (Zabala et al. 2008, 2011), or during three repeated 
high-intensity swimming bouts separated by 20 min (Pierce 
et al. 1992). Zabala et al. (2008) showed that neither pH, 
nor  HCO3− recovered back to baseline levels between the 
three Wingate tests, suggesting that the recovery of pH and 
 HCO3− to this level may be important to produce ergogenic 
effects in the subsequent exercise bouts.
Despite the promising effects of  NaHCO3 ingestion to 
improve repeated bouts of exercise in normoxia, this strat-
egy has yet to be applied to acute hypoxia. Nonetheless, 
Robergs et al. (2005) reported the use of  NaHCO3 combined 
with sodium citrate lead to post-exercise recovery of pH 
and  HCO3− to baseline in approximately 50 min at 1570 m 
terrestrial altitude, whereas the placebo condition failed to 
recover to baseline within the 80 min sampling period. Rob-
ergs et al. (2005) featured no subsequent bout of exercise, 
however, and it is also unclear if the participant cohort com-
pleted an acclimatisation period in the terrestrial altitude 
location. This enhanced post-exercise recovery displayed by 
Robergs et al. (2005) is potentially important, nonetheless, 
as athletes may complete multiple bouts of high-intensity 
exercise to maximise the adaptation from hypoxic training 
schedules, therefore, highlighting the need for optimal recov-
ery. The use of pre-exercise  NaHCO3 ingestion may, in turn, 
result in a blunting of the initial stress of acid–base balance 
during an initial bout of exercise, but also improve recovery, 
leading to improved subsequent exercise performance. This 
may have a cumulative effect in sustaining training volume 
and intensity during hypoxic training schedules, particularly 
considering chronic  NaHCO3 ingestion has been shown to be 
effective at improving performance following training sched-
ules at sea level (Egger et al. 2014; Durkalec-Michalski et al. 
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2018). The aim of this study, therefore, was to investigate the 
effects of both 0.2 g kg−1 BM and 0.3 g kg−1 BM  NaHCO3 
on repeated bouts of 4 km TT cycling performance in acute 
moderate hypoxic conditions. The hypothesis of this study 
was that both doses of  NaHCO3 would improve both bouts of 
exercise compared to the placebo; however, 0.3 g kg−1 BM 
 NaHCO3 would improve performance to the greatest extent.
Methods
Participants and compliance with ethical standards
Ten trained male cyclists (age 27 ± 8 years, body mass 
82 ± 9 kg, hypoxic maximal rate of oxygen uptake (VO2max) 
48.5 ± 5.6 ml kg min−1, and hypoxic peak power output 
331 ± 40 W) volunteered for this study. All participants’ 
training load was reflective of a ‘trained’ cyclist (De Pauw 
et al. 2013). Ethical approval was granted from the Uni-
versities Research Ethics Committee (URESC16-LG01; 
Edge Hill University), and all participants provided written 
informed consent.
Experimental overview
Using methods previously described (Gough et al. 2017b), 
an initial maximal rate of oxygen uptake (VO2max) test was 
conducted in a normobaric hypoxic chamber set at a fraction 
of inspired oxygen  (FiO2) of 14.5% (~ 3000 m). Participants 
then visited the laboratory on a further six separate occa-
sions in a block randomized, crossover, and double-blind 
designed study (2 × identification of peak blood  HCO3−, 
and 4 × cycling TTs). Individual time to peak  HCO3− was 
determined prior to the cycling time trials, using a previ-
ously described method (Gough et al. 2017c). This entailed 
participants ingesting either 0.2 g kg−1 BM  NaHCO3 (SBC2) 
or 0.3 g kg−1 BM  NaHCO3 (SBC3) on separate occasions, 
followed by a quiet rest for 180 min. Finger prick capillary 
blood samples were taken every 10 min, and the highest 
value of  HCO3− was then used as the individual time to 
peak. Twenty-four hours prior to each cycling TT, partici-
pants refrained from consumption of alcohol and caffeine, 
any strenuous activity, and maintenance of nutritional intake, 
which was confirmed via use of written nutrition/training 
diaries. Finally, participants were verbally screened to 
ensure avoidance of beta alanine ingestion had not occurred 
prior to enrolment onto the study, to account for the long 
washout of carnosine (Baguet et al. 2009).
Time trial protocol, supplementation of sodium 
bicarbonate, and blood measures
Participants completed 2 × 4 km TTs  (TT1 and  TT2) inter-
spersed with a 40 min recovery. The protocols for the 
TT, including the self-selected warm-up, were identical 
to those detailed in the previous research (Gough et al. 
2017c), whereby only cadence and gear was displayed to 
the participant. Each TT series was preceded by supple-
mentation of one of the SBC2, SBC3, or a taste-matched 
placebo (0.07 g kg−1 BM sodium chloride; PLA) admin-
istered in a block-randomized order. The randomisation 
of supplements was carried out by an individual who 
was not involved in the research, and performance times 
remained double-blind until completion of the study. Par-
ticipants remained seated until their respective pre-deter-
mined time to peak  HCO3− in normoxic conditions. Once 
reached, participants then entered the normobaric hypoxic 
chamber  (FiO2 14.5%) for 10 min, prior to beginning the 
 TT1 warm-up. Following  TT1, participants completed a 
passive recovery entailing a quiet seated rest for 40 min 
within the hypoxic environment. Finger prick capillary 
blood samples for acid–base balance (pH and  HCO3−), 
electrolytes  (K+,  Na+,  Ca2+, and  Cl−), lactate, and hae-
moglobin saturation with oxygen  (SpO2) were recorded 
pre-exercise, at time to peak  HCO3−, immediately post-
exercise and at 10 min intervals during the 40 min passive 
recovery. These blood samples were immediately ana-
lysed using a reliable blood gas analyser (ABL800BA-
SIC, Radiometer Medical ltd., Denmark), apart from 
lactate, which was analysed using a reliable and accurate 
lactate pro 2 analyser (Arkray, Japan) (Pyne et al. 2000; 
Bonaventura et al. 2015). To maintain the double-blind 
nature of the study, the screen on the blood gas analyser 
was covered, and an individual who was not part of the 
research stored the data until completion of the study. 
Calculation of the apparent SID was conducted using the 
formula  ([K+] + [Na+] + [Ca2+] + [Na+] − [Cl−] − [Lac−]) 
(Lloyd 2004). Afterwards, participants completed the  TT2 
warm-up, followed by  TT2. Additional blood samples were 
obtained following the warm-up in  TT2 and immediately 
post  TT2 for the same measures previously described.
Perceptual measures
Rating of perceived exertion for overall body exertion 
 (RPEO) and the legs  (RPEL) was recorded during  TT1 and 
 TT2 every 1 km, whilst HR and  SPO2 were recorded dur-
ing both  TT1 and  TT2 at every 500 m split and at 10 min 
intervals during recovery. Gastrointestinal (GI) discom-
fort was recorded at 10 min intervals after ingestion of 
the supplement (i.e., SBC2, SBC3, or PLA) up to the 
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individual time to peak  HCO3−, and at 10 min intervals 
during the 40 min recovery. At individual time to peak 
 HCO3−, participants were asked if they could determine 
which supplement they had ingested using a supplement 
belief questionnaire.
Statistical analysis
No evidence of a violation for normality and sphericity was 
evident in any assessed variable, and therefore, the appro-
priate parametric statistical tests were employed. A paired t 
test was conducted for the following: both the time to peak 
and absolute change in pH and  HCO3−, and both the severity 
and aggregated score for GI discomfort following SBC treat-
ments. Performance data (time to TT completion and mean 
power) and blood parameters (change in pH and  HCO3− dur-
ing  TT1, recovery, and  TT2) were analysed using a repeated 
measures ANOVA. In addition, magnitude-based inferences 
(MBI) with 90% confidence intervals (CI) were calculated 
for performance data and interpreted using an adapted 
method from a freely available spreadsheet (Batterham and 
Hopkins 2006). The thresholds to depict a benefit or harm 
were set as the typical error of the 4 km TT when converted 
from a percentage to an absolute value. This was completed 
by calculating the difference score in each individual, then 
calculating the standard deviation of the difference scores, 
and finally by dividing this by √2 (Swinton et al. 2018). 
This was used as in many cases, the 0.2 small effect size 
of Cohen d (Cohen 1988) is less than the typical error and, 
therefore, produces inflated positive results. Otherwise, a 
two-way [treatment × time] repeated measures ANOVA was 
conducted with a Bonferroni correction. Effect size for inter-
actions is reported as partial eta squared (Pη2) and where 
appropriate, between treatment Hedge’s g effect sizes (g) 
are reported and interpreted as per conventional thresholds 
(Cohen 1988). Significant effects are displayed with 95% CI 
where appropriate. Reproducibility of the absolute changes 
in pH and  HCO3− in the preliminary trial and the subsequent 
cycling trials was assessed using intraclass correlation coef-
ficients (ICC). Data are reported as mean ± standard devia-
tion (SD) and statistical significance was set at p < 0.05. Data 
were analysed using a statistical software package, SPSS 
(V.22, IBM Inc., Chicago, IL, USA).
Results
Preliminary trials to determine time to peak blood 
bicarbonate
Time to peak pH ranged between 30 and 100 min in SBC2 
(mean 66 ± 22 min; median 60 min; CV 34%) and between 
40 and 120 min in SBC3 (mean 76 ± 21 min; median 75 min; 
CV 27%; p = 0.04). The absolute change from baseline to 
peak pH was similar in SBC2 and SBC3 (0.08 ± 0.02 vs. 
0.09 ± 0.02; p = 0.27). In the subsequent cycling trials, 
the reproducibility of the absolute change in pH was fair 
in SBC2 (r = 0.50, p = 0.09) and good in SBC3 (r = 0.60, 
p = 0.06). Time to peak  HCO3− was achieved between 30 
and 110 min in SBC2 (mean 67 ± 21 min; median 60 min; 
CV 31%) compared to between 50 and 100 min in SBC3 
(mean 77 ± 17 min; median 75 min; CV 22%; p = 0.20). The 
absolute change from baseline was greater (+ 1 mmol l−1) in 
SBC3 compared to SBC2 (7.1 ± 1.2 vs. 6.0 ± 0.9 mmol l−1; 
p = 0.04; g = 1.0). In the subsequent cycling trials, the repro-
ducibility of the change from baseline to peak  HCO3− was 
good in SBC2 (r = 0.70, p = 0.04) and excellent in SBC3 
(r = 0.77, p = 0.02).
Performance
The decline in performance from  TT1 to  TT2 was similar 
in all treatments (SBC2 8.0 ± 6.8 vs. SBC3 7.0 ± 6.3 vs. 
PLA 7.3 ± 6.4 s; p > 0.05). In  TT1, SBC3 improved per-
formance compared to PLA by 1.4 ± 1.5% (400.2 ± 24.1 
vs. 405.9 ± 26.0 s; p = 0.03; CI = 10.6, 0.8; g = 0.2; Fig. 1), 
which was determined as a very likely benefit in MBI analy-
sis. Meanwhile, SBC2 displayed a likely benefit compared to 
PLA, improving performance by 0.9 ± 1.1% (402.3 ± 26.5 s; 
p = 0.14; g = 0.1; Fig. 1. A likely benefit was also observed 
in SBC3 vs. SBC2 (p = 0.15; g = 0.1). Findings were simi-
lar in  TT2, where SBC3 again displayed the fastest comple-
tion times by 1.4 ± 1.1% compared to PLA (407.2 ± 29.2 vs. 
413.2 ± 30.8 s; p = 0.01; CI = 10.5, 1.5; g = 0.2), which MBI 
analysis determined this as a very likely effect. Whereas, 
SBC2 improved performance by 0.7 ± 1.2% compared to 
PLA (410.3 ± 30.8 s) and this was determined as a likely 
benefit (p = 0.35; g = 0.1; Fig. 2). A possible benefit was 
determined for SBC3 compared to SBC2 for  TT2 comple-
tion time (p = 0.44; g = 0.1).
Fig. 1  Mean (± SD) and individual (horizontal lines) time to com-
plete time trial 1  (TT1) following SBC2, SBC3, and PLA. Asterisk 
denotes significantly improved compared to PLA (p < 0.05)
2493European Journal of Applied Physiology (2018) 118:2489–2498 
1 3
Mean power in  TT1 was 4.1% greater in SBC3 compared 
to PLA (247 ± 41 vs. 258 ± 41; p = 0.03; CI = 1.7, 19.6; 
g = 0.3), showing a very likely improvement. Meanwhile, 
SBC2 improved mean power by 2.5% compared to PLA, 
also revealing a very likely benefit (vs. 254 ± 43 W; p = 0.68; 
g = 0.2). A likely benefit was determined for SBC3 vs. SBC2 
(p = 0.39; g = 0.1). Mean power in  TT2 was improved by 
3.8% in SBC3 compared to PLA (247 ± 46 vs. 237 ± 47 W; 
p = 0.005; CI = 3.0, 15.5; g = 0.2), and demonstrated a most 
likely benefit. Whereas, a likely benefit was determined in 
SBC2 (vs. 242 ± 47 W; p = 0.34; g = 0.1). A likely benefit 
was determined for SBC3 vs. SBC2 (p = 0.48; g = 0.1).
Blood responses
A [treatment × time] interaction was observed for 
 HCO3− (Pƞ2 = 0.65, p < 0.001), as  HCO3− was greater post-
supplementation of  NaHCO3 in SBC3 compared to both 
SBC2 (p = 0.02; CI = 0.3, 2.5, g = 1.5) and PLA (p < 0.001; 
CI = 6.3, 7.9; g = 8.4; Fig. 3). Whereas, SBC2 was greater 
than PLA only (p < 0.001; CI = 4.4, 7.1; g = 5.7). Post  TT1, 
 HCO3− was greater in both SBC2 and SBC3 compared to 
PLA (both p < 0.001), with no differences between SBC 
conditions (p = 0.38). There was a [treatment] effect for 
 HCO3− change during  TT1 (Pƞ2 = 0.69, p < 0.001), whereby 
both SBC2 and SBC3 were greater than PLA (p < 0.005), 
with a small effect size between SBC treatments (10.6 ± 3.4 
vs. 11.5 ± 3.2  mmol  l−1; p = 0.63; g = 0.26). A signifi-
cant [treatment × time] interaction was observed for pH 
(Pƞ2 = 0.36, p = 0.002), as pH was greater post-supplementa-
tion and post-TT1 warm-up in SBC3 compared to both SBC2 
and PLA (both p < 0.01), whilst SBC2 was greater compared 
to PLA (p < 0.001). Blood lactate was greater post-TT1 in 
both SBC treatments compared to PLA (p < 0.005), with no 
differences observed otherwise (all p > 0.05; Fig. 3).
Both SBC treatments elicited reductions in  K+,  Ca2+, and 
 Cl−, and increases in  Na+ compared to PLA (Fig. 4). The 
SID at post-TT1 warm-up and post-TT1 was greater in both 
SBC treatments compared to PLA (p < 0.005). However, the 
SID in SBC3 was greater than SBC2 post-NaHCO3 supple-
mentation (p = 0.005; CI = 0.7, 3.5; g = 1.0) and post-TT1 
warm-up (p = 0.049; CI = 0.01, 3.6; g = 0.8; Fig. 5). During 
recovery,  HCO3− was greater following SBC3 compared to 
PLA at all recovery timepoints (p < 0.01), however, only 
greater at 20 (23.5 ± 1.7 mmol l−1; 21.1 ± 2.7 mmol l−1; 
p = 0.04; CI = 0.2, 4.7; g = 1.0) and 40 min (27.7 ± 0.8 vs. 
25.7 ± 1.3 mmol l−1; p = 0.006; CI = 0.6, 3.3; g = 1.8) com-
pared to SBC2. Similarly, SBC2 was greater than PLA at all 
recovery timepoints (all p < 0.01). The absolute change in 
 HCO3− from post  TT1 to 40 min recovery was significantly 
greater compared to PLA (5.0 ± 1.5 mmol l−1) in both SBC2 
Fig. 2  Mean (± SD) and individual (horizontal lines) time to com-
plete time trial 2  (TT2) following SBC and PLA treatments. Asterisk 
denotes significantly improved compared to PLA (p < 0.05)
Fig. 3  Mean (± SD) responses for blood a pH, b bicarbonate 
 (HCO3−), and c lactate following  NaHCO3 across time. SBC3 (aster-
isk) and SBC2 (hash symbol) significantly greater than PLA. SBC3 
(dagger symbol) significantly greater than SBC2 (p < 0.05). R recov-
ery, PW post warm-up
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(10.1 ± 1.4 mmol l−1, p < 0.001; CI = 3.2, 7.1; g = 3.4) and 
SBC3 (11.1 ± 2.5 mmol l−1, p < 0.001; CI = 4.2, 8.1; g = 2.8), 
with a small effect size between SBC treatments (p = 0.45; 
g = 0.3). The absolute change in the SID from post-TT1 to 
40 min recovery was only significantly greater for SBC3 
compared to PLA (p = 0.05; CI = 0.01, 9.0; g = 1.2).
Post warm-up in  TT2,  HCO3− was greater in both SBC2 
and SBC3 compared to PLA (p < 0.001); however, SBC3 
was greater than any treatment (p < 0.001). There was a 
[treatment] effect for  HCO3− change during  TT2 (Pƞ2 = 0.71, 
p < 0.001), whereby both SBC treatments were greater than 
PLA (p < 0.01); however, SBC3 was greater compared to 
SBC2 (10.7 ± 2.9 vs. 9.2 ± 2.7 mmol l−1; p = 0.02; CI = 0.3, 
2.6; g = 0.5; Fig. 3). Post-TT2 warm-up, and post-TT2, pH in 
both SBC2 and SBC3 were greater than PLA (p < 0.001), 
although no differences between SBC treatments were 
observed (p > 0.05). Blood lactate was greater post-TT2 in 
both SBC2 (18.0 ± 4.2 vs. 14.4 ± 3.3 mmol l−1; p = 0.05; 
CI = − 0.01, 7.2; g = 0.9) and SBC3 (18.6 ± 3.5 mmol l−1; 
p = 0.009; CI = 1.1, 7.2; g = 0.9) compared to PLA, with no 
difference between SBC treatments (p = 0.424; g = 1.2). Post-
TT2 warm-up, the SID was greater for both SBC2 and SBC3 
compared to PLA (p < 0.001); however, no difference was 
observed between SBC treatments (SBC2 35 ± 3 vs. SBC3 
37 ± 3 meq/L; p = 0.20; g = 0.6).
Perceptual responses
During  TT1,  NaHCO3 did not affect  RPEO (Pƞ2 = 0.24, 
p = 0.07) or  RPEL (Pƞ2 = 0.10, p = 0.38), HR (Pƞ2 = 0.07, 
p = 0.63), or  SPO2 (Pƞ2 = 0.18, p = 0.16). Similarly, in  TT2, 
no changes in  RPEO (Pƞ2 = 0.17, p = 0.12),  RPEL (Pƞ2 = 0.11, 
p = 0.35), HR (Pƞ2 = 0.07, p = 0.78), or  SPO2 (Pƞ2 = 0.02, 
p = 0.83) were observed.
Gastrointestinal (GI) discomfort
In total, 6/10 (60%) participants suffered from GI discomfort 
in SBC2, whereas 9/10 (90%) suffered from GI discomfort 
Fig. 4  Mean (± SD) potassium (a), sodium (b), calcium (c), and 
chloride (d) responses over time following SBC treatments. SBC3 
(asterisk) and SBC2 (hash symbol) significantly different compared 
to PLA. SBC3 (dagger symbol) significantly different compared to 
SBC2 (p < 0.05). R recovery, PW post warm-up
Fig. 5  Mean (± SD) strong ion difference (SID) responses over time 
following SBC treatments. SBC3 (asterisk) and SBC2 (hash symbol) 
significantly greater than PLA. SBC3 (dagger symbol) significantly 
greater than SBC2 (p < 0.05). R recovery, PW post warm-up
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in SBC3. The most common GI discomfort symptom was 
belching (2/10) in SBC2, whilst in SBC3, diarrhoea, bowel 
urgency, and feeling of vomiting were most common (5/10). 
Both the aggregated GI discomfort and the severity of the 
most severe GI discomfort symptom suffered were greater 
in SBC3 compared to SBC2 (both p < 0.05, Fig. 6). On 3/30 
(10%) occasions, the supplement was correctly identified 
by the participant.
Discussion
This study investigated the effects of  NaHCO3 ingestion 
on post-exercise acid–base balance recovery and repeated 
4 km TT performance in moderate acute hypoxic conditions. 
Both SBC2 and SBC3 improved  TT1 and  TT2 performance 
compared to PLA, displaying ‘likely’ and ‘very likely’ 
beneficial effects in magnitude-based inferences analysis, 
respectively. The current study findings suggest that this 
occurred due to the greater magnitude of acid–base balance 
recovery between  TT1 and  TT2 or that the initial acid–base 
balance stress during  TT1 was blunted by  NaHCO3 inges-
tion. A greater magnitude of performance improvement was 
observed in SBC3, however, showing ‘likely’ and ‘possi-
bly’ beneficial effects in  TT1 and  TT2 compared to SBC2, 
respectively. As such, SBC3 is the most optimal to improve 
repeated efforts of high-intensity exercise in acute moder-
ate hypoxic conditions. One individual did display an ergo-
lytic effect following SBC3, however, despite still gaining 
ergogenic effects from SBC2 vs. PLA, possibly caused by 
the onset of severe GI discomfort (Saunders et al. 2014). 
Individuals who display similar responses may, therefore, 
wish to select SBC2.
The current study findings suggest the enhanced exercise 
performance in both bouts of exercise following  NaHCO3 
ingestion occurred due to the combination of the greater 
alkalotic state of the acid–base balance prior to  TT1 and 
the greater magnitude of acid–base balance recovery prior 
to  TT2. The change in  HCO3− during  TT1 was increased 
following  NaHCO3 (SBC2 + 29%, SBC3 + 34%), whilst 
post  TT1, blood lactate was also greater compared to PLA 
(SBC2 + 21%, SBC3 + 23%). These changes suggest an 
increased  H+ buffering from intramuscular to extracellular 
compartments, which may lead to an increased anaerobic 
energy provision and glycogen utilization, as intramuscu-
lar pH is better protected (Lopes-Silva et al. 2018; Percival 
et al. 2015). It is argued that these indirect biomarkers of 
upregulated glycolytic flux in the present study instead 
show a reduction in lactate by inactive tissue however, as 
the samples in the present study do provide data on use/
uptake (Granier et al. 1996). Likewise, it is strongly argued 
that acidosis does not inhibit contractile machinery and that 
alkalization may cause instability of the buffering systems, 
and thus, the benefit to the ATP-generating process is either 
negligible, or actually harmful (Korzeniewski and Zoladz 
2002; Sahlin et al. 1998). A recent study by Lopes-Silva 
et al. (2018), nonetheless, reported similar post-exercise 
 HCO3− and lactate responses to the current study follow-
ing  NaHCO3 ingestion, yet also reported both a 34% greater 
estimated glycolytic energy contribution to exercise and an 
improved performance. It is alternately conceivable that the 
increases in  HCO3− and  CO2 following  NaHCO3 ingestion 
are part of a causal sequence of the primary mechanism 
of performance, by accelerating VO2 kinetics at the onset 
of high-power outputs (Zoladz et al. 2005). Unfortunately, 
VO2 was not measured during the TTs in the study, so this 
cannot be concluded and thus warrants further research. The 
current study findings, nonetheless, further support past 
research (Fitts 2016) that acid–base balance disturbances 
are an important determinant of fatigue during high-intensity 
exercise.
The current study adds that  NaHCO3 ingestion increased 
the SID prior to each TT bout, which may explain the 
improved performance. The SID has been suggested to be 
an important component of action potentials by increasing 
muscle excitability (Allen et al. 2008). Notable changes 
Fig. 6  Individual aggregated score and severity of gastrointestinal (GI) responses following SBC treatments. Asterisk denotes SBC3 signifi-
cantly greater than SBC2 (p < 0.05)
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 NaHCO3 ingestion elicits include a lowering of extracel-
lular  K+ and  Cl−, whilst increasing  Na+, all of which have 
collectively been identified to be important for muscle con-
traction during high-intensity exercise previously (Cairns 
and Lindinger 2008). Here, the current study findings 
expand upon those of Sostaric et al. (2006) that reported an 
improvement in finger flexion to exhaustion combined with 
an increased SID following  NaHCO3 ingestion, by showing 
a similar effect but during dynamic whole-body exercise. 
These findings also provide an alternative mechanism to 
the pH and  HCO3−-mediated mechanisms often criticised 
in the literature (Westerblad 2016). It is worth noting that 
the highlighted changes in the SID may also have further 
reaching benefits to health-related outcomes. Mild meta-
bolic acidosis has been linked with multiple health-related 
outcomes including protein metabolism, by decreasing 
synthesis through increases of non-enzymatic proteolysis 
(Wiederkehr and Krapf 2001). Likewise, regular consump-
tion of alkaline rich supplements has been shown to improve 
mineral balance and rate of bone formation (Sebastian et al. 
1994). Therefore, more research is required investigating the 
use of chronic  NaHCO3 ingestion in sporting populations 
that could also be prone to such issues, particularly endur-
ance runners and adolescent athletes (Tenforde et al. 2017; 
Scofield and Hecht 2012).
Both pH and  HCO3− following SBC treatments were 
increased prior to  TT2, such that the absolute change in 
 HCO3− from  TT1 to 40 min recovery was over twofold 
greater compared to PLA (SBC2 + 51%, SBC3 + 55%), 
whilst the change in the SID was also more superior 
(SBC2 + 29%, SBC3 + 31%). This suggests a greater amount 
of  H+ buffering occurred during this time, which subse-
quently facilitated a more substantial recovery of acid–base 
balance compared to PLA, in support of previous research 
(Pruscino et al. 2008; Gough et al. 2017a). Alternatively, 
the improvement in  TT2 may have been due to the stress on 
acid–base balance being blunted by  NaHCO3 during  TT1, as 
pH,  HCO3−, and the SID were all greater immediately post 
 TT1 compared to PLA. Based on data from Gough et al. 
(2017a), however, it is more likely that the enhancement of 
the acid–base balance state between  TT1 and  TT2 explains 
the improvement in the current study, as the authors reported 
 NaHCO3 ingestion improved a subsequent exercise even 
when supplementation was after an initial bout of exercise. 
Moreover, SBC3 elicited a significantly greater magnitude 
of acid–base balance recovery prior to  TT2, and change in 
 HCO3− during  TT2 compared to SBC2. Correspondingly, 
SBC3 improved performance within half of the sample com-
pared to SBC2, compared to only two displaying greater 
improvements in SBC2 vs. SBC3 when using the 3.1 s TE 
of the test. Combined, these greater increases in acid–base 
balance blood analytes may explain the greater magnitude 
of improvement in  TT2 produced by SBC3.
At 40  min recovery pH,  HCO3− and the SID were 
still rising following  NaHCO3 ingestion, such that pH 
at 40 min recovery was 7.49 ± 0.02 in SBC3, which was 
identical to the increase prior to  TT1 following the same 
dose (7.49 ± 0.01). This is in agreement with the previ-
ous research in normoxia showing similar increases at the 
end of a recovery period typically seen with pre-exercise 
 NaHCO3 ingestion (Callaghan et al. 2017; Pruscino et al. 
2008). Equally, in the current study, and others (Callaghan 
et al. 2017; Pruscino et al. 2008), acid–base balance sta-
tus was still significantly rising to a more alkalotic state. 
It is plausible to suggest, therefore, if a longer period of 
recovery was employed, a more pronounced performance 
effect may have been observed compared to PLA. Moreo-
ver, this also suggests that re-dosing  NaHCO3 following 
an initial fatiguing bout is not required, as acid–base bal-
ance increased well above baseline, despite no re-dosing 
of  NaHCO3. These findings may be of importance to indi-
viduals who suffer from GI discomfort, as no instances 
were reported during recovery in the current study. Future 
research should, therefore, investigate the performance 
responses on repeated exercise following  NaHCO3 inges-
tion with a longer period of recovery.
One participant presented an ergolytic effect in both  TT1 
and  TT2 after ingestion of SBC3. This was likely due to 
the occurrence of severe GI discomfort (diarrhoea = 10; 
aggregate score = 63), as this participant still improved their 
performance in SBC2. These findings support the previous 
research, whereby ergolytic effects were observed in par-
ticipants who suffered from severe GI discomfort following 
0.3 g kg−1 BM  NaHCO3 (Saunders et al. 2014; Froio de 
Araujo Dias et al. 2015). It is therefore important to monitor 
the GI discomfort responses following  NaHCO3 ingestion on 
an individual basis, as those who display severe symptoms 
following SBC3 may instead benefit from ingesting SBC2. 
The use of this smaller dose, however, will be dependent on 
an improvement in performance still being observed com-
pared to a placebo.
Conclusion
This study investigated the effects of  NaHCO3 ingestion 
on repeated 4  km TT performance and acid–base bal-
ance recovery in acute moderate hypoxic conditions. Both 
amounts of  NaHCO3 employed in this study ensured recov-
ery of acid–base balance back to baseline or above within 
20–40 min, whereas this was not achieved for PLA. For 
the first time, blunting of the acid–base balance stress dur-
ing the initial bout of exercise, or a greater magnitude of 
acid–base balance recovery, has translated into improved 
subsequent high-intensity exercise performance following 
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 NaHCO3 ingestion in acute hypoxic conditions. The perfor-
mance improvement was greater in SBC3, which is likely 
due to the greater alkalotic status of acid–base balance both 
prior to  TT1, and during recovery compared to SBC2 and 
PLA. The onset of GI discomfort was an issue with SBC3, 
however, and one participant displayed an ergolytic effect on 
performance following this dose. Individuals should, there-
fore, employ SBC3 to improve performance in acute hypoxic 
conditions, only if severe GI discomfort does not occur.
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